CRISPR Therapeutics AG

NASDAQ:CRSP

48.94 (USD) • At close September 13, 2024
Bedrijfsnaam CRISPR Therapeutics AG
Symbool CRSP
Munteenheid USD
Prijs 48.94
Beurswaarde 4,168,131,708
Dividendpercentage 0%
52-weken bereik 37.55 - 91.1
Industrie Biotechnology
Sector Healthcare
CEO Dr. Samarth Kulkarni Ph.D.
Website https://www.crisprtx.com

An error occurred while fetching data.

Over CRISPR Therapeutics AG

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA. The company has a portfolio

Vergelijkbare Aandelen

QuidelOrtho Corporation logo

QuidelOrtho Corporation

QDEL

45.47 USD

iRhythm Technologies, Inc. logo

iRhythm Technologies, Inc.

IRTC

76.61 USD

ICU Medical, Inc. logo

ICU Medical, Inc.

ICUI

179 USD

Tandem Diabetes Care, Inc. logo

Tandem Diabetes Care, Inc.

TNDM

43.97 USD

Apellis Pharmaceuticals, Inc. logo

Apellis Pharmaceuticals, Inc.

APLS

37.62 USD

The Ensign Group, Inc. logo

The Ensign Group, Inc.

ENSG

152.73 USD

Cerevel Therapeutics Holdings, Inc. logo

Cerevel Therapeutics Holdings, Inc.

CERE

44.96 USD

Medpace Holdings, Inc. logo

Medpace Holdings, Inc.

MEDP

351.67 USD

Lantheus Holdings, Inc. logo

Lantheus Holdings, Inc.

LNTH

105.55 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)